Multicenter study of antimicrobial susceptibility of anaerobic bacteria in Korea in 2012

Yangsoon Lee, Yeon Joon Park, Mi Na Kim, Young Uh, Myung Sook Kim, Kyungwon Lee

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: Periodic monitoring of regional or institutional resistance trends of clinically important anaerobic bacteria is recommended, because the resistance of anaerobic pathogens to antimicrobial drugs and inappropriate therapy are associated with poor clinical outcomes. There has been no multicenter study of clinical anaerobic isolates in Korea. We aimed to determine the antimicrobial resistance patterns of clinically important anaerobes at multiple centers in Korea. Methods: A total of 268 non-duplicated clinical isolates of anaerobic bacteria were collected from four large medical centers in Korea in 2012. Antimicrobial susceptibility was tested by the agar dilution method according to the CLSI guidelines. The following antimicrobials were tested: piperacillin, piperacillin-tazobactam, cefoxitin, cefotetan, imipenem, meropenem, clindamycin, moxifloxacin, chloramphenicol, metronidazole, and tigecycline. Results: Organisms of the Bacteroides fragilis group were highly susceptible to piperacillin-tazobactam, imipenem, and meropenem, as their resistance rates to these three antimicrobials were lower than 6%. For B. fragilis group isolates and anaerobic gram-positive cocci, the resistance rates to moxifloxacin were 12-25% and 11-13%, respectively. Among B. fragilis group organisms, the resistance rates to tigecycline were 16-17%. Two isolates of Finegoldia magna were non-susceptible to chloramphenicol (minimum inhibitory concentrations of 16-32 mg/L). Resistance patterns were different among the different hospitals. Conclusions: Piperacillin-tazobactam, cefoxitin, and carbapemems are highly active β-lactam agents against most of the anaerobes. The resistance rates to moxifloxacin and tigecycline are slightly higher than those in the previous study.

Original languageEnglish
Pages (from-to)479-486
Number of pages8
JournalAnnals of laboratory medicine
Volume35
Issue number5
DOIs
Publication statusPublished - 2015 Sep 1

Fingerprint

meropenem
Bacteroides fragilis
Anaerobic Bacteria
Korea
Multicenter Studies
Cefoxitin
Bacteria
Imipenem
Chloramphenicol
Cefotetan
Lactams
Gram-Positive Cocci
Piperacillin
Clindamycin
Metronidazole
Microbial Sensitivity Tests
Pathogens
Dilution
Agar
Guidelines

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Lee, Yangsoon ; Park, Yeon Joon ; Kim, Mi Na ; Uh, Young ; Kim, Myung Sook ; Lee, Kyungwon. / Multicenter study of antimicrobial susceptibility of anaerobic bacteria in Korea in 2012. In: Annals of laboratory medicine. 2015 ; Vol. 35, No. 5. pp. 479-486.
@article{b9d50f10a9454722bd7c1cb5136f1467,
title = "Multicenter study of antimicrobial susceptibility of anaerobic bacteria in Korea in 2012",
abstract = "Background: Periodic monitoring of regional or institutional resistance trends of clinically important anaerobic bacteria is recommended, because the resistance of anaerobic pathogens to antimicrobial drugs and inappropriate therapy are associated with poor clinical outcomes. There has been no multicenter study of clinical anaerobic isolates in Korea. We aimed to determine the antimicrobial resistance patterns of clinically important anaerobes at multiple centers in Korea. Methods: A total of 268 non-duplicated clinical isolates of anaerobic bacteria were collected from four large medical centers in Korea in 2012. Antimicrobial susceptibility was tested by the agar dilution method according to the CLSI guidelines. The following antimicrobials were tested: piperacillin, piperacillin-tazobactam, cefoxitin, cefotetan, imipenem, meropenem, clindamycin, moxifloxacin, chloramphenicol, metronidazole, and tigecycline. Results: Organisms of the Bacteroides fragilis group were highly susceptible to piperacillin-tazobactam, imipenem, and meropenem, as their resistance rates to these three antimicrobials were lower than 6{\%}. For B. fragilis group isolates and anaerobic gram-positive cocci, the resistance rates to moxifloxacin were 12-25{\%} and 11-13{\%}, respectively. Among B. fragilis group organisms, the resistance rates to tigecycline were 16-17{\%}. Two isolates of Finegoldia magna were non-susceptible to chloramphenicol (minimum inhibitory concentrations of 16-32 mg/L). Resistance patterns were different among the different hospitals. Conclusions: Piperacillin-tazobactam, cefoxitin, and carbapemems are highly active β-lactam agents against most of the anaerobes. The resistance rates to moxifloxacin and tigecycline are slightly higher than those in the previous study.",
author = "Yangsoon Lee and Park, {Yeon Joon} and Kim, {Mi Na} and Young Uh and Kim, {Myung Sook} and Kyungwon Lee",
year = "2015",
month = "9",
day = "1",
doi = "10.3343/alm.2015.35.5.479",
language = "English",
volume = "35",
pages = "479--486",
journal = "Annals of Laboratory Medicine",
issn = "2234-3806",
publisher = "Seoul National University",
number = "5",

}

Multicenter study of antimicrobial susceptibility of anaerobic bacteria in Korea in 2012. / Lee, Yangsoon; Park, Yeon Joon; Kim, Mi Na; Uh, Young; Kim, Myung Sook; Lee, Kyungwon.

In: Annals of laboratory medicine, Vol. 35, No. 5, 01.09.2015, p. 479-486.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Multicenter study of antimicrobial susceptibility of anaerobic bacteria in Korea in 2012

AU - Lee, Yangsoon

AU - Park, Yeon Joon

AU - Kim, Mi Na

AU - Uh, Young

AU - Kim, Myung Sook

AU - Lee, Kyungwon

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Background: Periodic monitoring of regional or institutional resistance trends of clinically important anaerobic bacteria is recommended, because the resistance of anaerobic pathogens to antimicrobial drugs and inappropriate therapy are associated with poor clinical outcomes. There has been no multicenter study of clinical anaerobic isolates in Korea. We aimed to determine the antimicrobial resistance patterns of clinically important anaerobes at multiple centers in Korea. Methods: A total of 268 non-duplicated clinical isolates of anaerobic bacteria were collected from four large medical centers in Korea in 2012. Antimicrobial susceptibility was tested by the agar dilution method according to the CLSI guidelines. The following antimicrobials were tested: piperacillin, piperacillin-tazobactam, cefoxitin, cefotetan, imipenem, meropenem, clindamycin, moxifloxacin, chloramphenicol, metronidazole, and tigecycline. Results: Organisms of the Bacteroides fragilis group were highly susceptible to piperacillin-tazobactam, imipenem, and meropenem, as their resistance rates to these three antimicrobials were lower than 6%. For B. fragilis group isolates and anaerobic gram-positive cocci, the resistance rates to moxifloxacin were 12-25% and 11-13%, respectively. Among B. fragilis group organisms, the resistance rates to tigecycline were 16-17%. Two isolates of Finegoldia magna were non-susceptible to chloramphenicol (minimum inhibitory concentrations of 16-32 mg/L). Resistance patterns were different among the different hospitals. Conclusions: Piperacillin-tazobactam, cefoxitin, and carbapemems are highly active β-lactam agents against most of the anaerobes. The resistance rates to moxifloxacin and tigecycline are slightly higher than those in the previous study.

AB - Background: Periodic monitoring of regional or institutional resistance trends of clinically important anaerobic bacteria is recommended, because the resistance of anaerobic pathogens to antimicrobial drugs and inappropriate therapy are associated with poor clinical outcomes. There has been no multicenter study of clinical anaerobic isolates in Korea. We aimed to determine the antimicrobial resistance patterns of clinically important anaerobes at multiple centers in Korea. Methods: A total of 268 non-duplicated clinical isolates of anaerobic bacteria were collected from four large medical centers in Korea in 2012. Antimicrobial susceptibility was tested by the agar dilution method according to the CLSI guidelines. The following antimicrobials were tested: piperacillin, piperacillin-tazobactam, cefoxitin, cefotetan, imipenem, meropenem, clindamycin, moxifloxacin, chloramphenicol, metronidazole, and tigecycline. Results: Organisms of the Bacteroides fragilis group were highly susceptible to piperacillin-tazobactam, imipenem, and meropenem, as their resistance rates to these three antimicrobials were lower than 6%. For B. fragilis group isolates and anaerobic gram-positive cocci, the resistance rates to moxifloxacin were 12-25% and 11-13%, respectively. Among B. fragilis group organisms, the resistance rates to tigecycline were 16-17%. Two isolates of Finegoldia magna were non-susceptible to chloramphenicol (minimum inhibitory concentrations of 16-32 mg/L). Resistance patterns were different among the different hospitals. Conclusions: Piperacillin-tazobactam, cefoxitin, and carbapemems are highly active β-lactam agents against most of the anaerobes. The resistance rates to moxifloxacin and tigecycline are slightly higher than those in the previous study.

UR - http://www.scopus.com/inward/record.url?scp=84942237977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942237977&partnerID=8YFLogxK

U2 - 10.3343/alm.2015.35.5.479

DO - 10.3343/alm.2015.35.5.479

M3 - Article

C2 - 26206683

AN - SCOPUS:84942237977

VL - 35

SP - 479

EP - 486

JO - Annals of Laboratory Medicine

JF - Annals of Laboratory Medicine

SN - 2234-3806

IS - 5

ER -